Fig. 3From: Biomarker discovery for practice of precision medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agentsPDE4D transfection and cellular TXT sensitivity. As in the case of RAB15, PDE4D overexpression in BICR6 transfectants (#6, #8, #9, and #10) (A) caused an increase of TXT resistance in association with the enhanced expression levels (B). Western blot analyses and quantification assay on the blots were performed for the target protein and β-actin (A) (See Supplemental Information File 1_Western Blot Raw Data)Back to article page